Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

T-Cell Therapy for Advanced Breast Cancer

Phase 1

Active, not recruiting

Conditions: Breast Cancer
Metastatic HER2-negative Breast

Interventions: Drug: Cyclophosphamide
Biological: Mesothelin-targeted T cells
Drug: AP1903

First Posted Date: 2016-06-07

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 186

Registration Number: NCT02792114

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Consent and follow-up only), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (Consent and follow-up only), Basking Ridge, New Jersey, United States

and more 4 locations

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Phase 1

Active, not recruiting

Conditions: Lymphoma
Relapsed/Refractory T-cell Lymphomas

Interventions: Drug: Romidepsin
Drug: Bortezomib
Drug: duvelisib

First Posted Date: 2016-05-26

Last Posted Date: 2025-06-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 114

Registration Number: NCT02783625

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
University of Washington School of Medicine in St. Louis, Saint Louis, Missouri, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

and more 8 locations

Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma

Phase 2

Active, not recruiting

Conditions: Adenoid Cystic Carcinoma

Interventions: Drug: Lenvatinib

First Posted Date: 2016-05-23

Last Posted Date: 2025-06-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 33

Registration Number: NCT02780310

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States

and more 2 locations

AASUR in High Risk Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: ARN-509
Drug: Abiraterone
Drug: Leuprolide
Radiation: stereotactic, ultra-fractionated radiotherapy

First Posted Date: 2016-05-13

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT02772588

Locations: 🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 8 locations

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: skin punch biopsy

First Posted Date: 2016-05-13

Last Posted Date: 2024-07-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 120

Registration Number: NCT02772367

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

Withdrawn

Conditions: Liver Cancer
Liver Metastases

Interventions: Procedure: Hepatic trans-arterial embolization (TAE)
Device: MRI/CT scan
Procedure: biopsy
Other: blood draw

First Posted Date: 2016-05-13

Last Posted Date: 2017-01-31

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT02772575

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Not Applicable

Completed

Conditions: C. Difficile Infection
Cancer

Interventions: Biological: Fecal Microbiota Transplantation (FMT)

First Posted Date: 2016-05-12

Last Posted Date: 2025-04-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT02770326

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Cancer

Interventions: Biological: TPIV200
Biological: Durvalumab

First Posted Date: 2016-05-06

Last Posted Date: 2021-11-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 29

Registration Number: NCT02764333

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Rockville, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 2 locations

A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma

Phase 1

Completed

Conditions: Lymphoma
Mantle Cell Lymphoma
Follicular Lymphoma
Diffuse Large B Cell Lymphoma

Interventions: Drug: Buparlisib
Drug: Ibrutinib

First Posted Date: 2016-04-29

Last Posted Date: 2022-10-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 37

Registration Number: NCT02756247

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 3 locations

Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy

Completed

Conditions: Breast Cancer

Interventions: Behavioral: qualitative interviews with patients
Behavioral: questionnaires

First Posted Date: 2016-04-28

Last Posted Date: 2020-04-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT02753673

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy